In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old
Pivotal Study of the Preceptis Medical Inc. Hummingbird™ Tympanostomy Tube System (H-TTS) in the Otolaryngology Clinic
1 other identifier
interventional
258
1 country
7
Brief Summary
The objective of this study is to evaluate the safety and performance of the Hummingbird® for the placement of ear tubes in children undergoing tympanostomy tube placement in an otolaryngology clinic using local anesthetic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2018
CompletedFirst Posted
Study publicly available on registry
June 1, 2018
CompletedStudy Start
First participant enrolled
July 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2022
CompletedResults Posted
Study results publicly available
December 14, 2022
CompletedDecember 14, 2022
November 1, 2022
4.1 years
May 9, 2018
September 22, 2022
November 18, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Rate of Ears Experiencing an Adverse Events From Enrollment to 3-10 Week Follow-up
AEs that occurred from enrollment through the 3-10 week follow-up were collected.
Follow-up between 3-10 weeks
Percentage of Ears With Successful Delivery of the Tympanostomy Tube by the H-TTS
Efficacy evaluation will consist of determining whether the H-TTS device successfully delivers the tympanostomy tube across the tympanic membrane.
Intra-Procedure
Percentage of Participants With Successful Completion of Procedure In-office
Success will be defined as the ability of the surgeon to place ear tubes using the H-TTS device in the office setting with the use of local anesthetic.
Intra-procedure
Study Arms (1)
Hummingbird Tympanostomy Tube System (H-TTS)
OTHERThe Hummingbird Tympanostomy Tube System (H-TTS) is a disposable surgical tool designed to deliver a tympanostomy tube ("ear tube") into the tympanic membrane of patients during a tympanostomy tube placement procedure.
Interventions
The H-TTS is intended to deliver a tympanostomy tube through the tympanic membrane of a patient during a tympanostomy procedure.
Eligibility Criteria
You may qualify if:
- Scheduled to undergo tympanostomy tube insertion in the clinic.
- Children 6 months to 21 years old
- Signed parental consent, and child assent documents as applicable.
- Parent is fluent in English.
You may not qualify if:
- Any condition that, in the opinion of the investigator, may place the subject at greater risk (e.g., child with developmental delay).
- Anatomy precludes sufficient visualization and access to the tympanic membrane.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Cedars-Sinai Medical Care Foundation
Beverly Hills, California, 90211, United States
Children's Ear Nose Throat & Allergy
Orlando, Florida, 32835, United States
HealthPartners Institute
Bloomington, Minnesota, 55425-4516, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
St. Cloud Ear, Nose & Throat
Saint Cloud, Minnesota, 56303, United States
Park Nicollet
Saint Louis Park, Minnesota, 55416, United States
Prairie Sinus Ear & Allergy, P.C.
Bismarck, North Dakota, 58503-0697, United States
Related Publications (1)
Truitt TO, Kosko JR, Nimmons GL, Raisen J, Skovlund SM, Rimell F, Cofer SA. In-office insertion tympanostomy tubes in children using single-pass device. Laryngoscope Investig Otolaryngol. 2021 Feb 2;6(2):325-331. doi: 10.1002/lio2.533. eCollection 2021 Apr.
PMID: 33869765DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Steve Anderson
- Organization
- Preceptis Medical
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2018
First Posted
June 1, 2018
Study Start
July 24, 2018
Primary Completion
September 6, 2022
Study Completion
September 12, 2022
Last Updated
December 14, 2022
Results First Posted
December 14, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make IPD available to other researchers.